Said C Farschtschi (Said Farschtschi)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Magnetic Resonance

Diffusion Weighted

Patient Reported Outcomes

Top Venues

Neuro-oncology advances

Cancer immunology, immunotherapy : CII

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Inka Ristow, Michael G Kaul, Maria Stark, Antonia Zapf, Christoph Riedel, Alexander Lenz, Victor F Mautner, Said C Farschtschi, Ivayla Apostolova, Gerhard Adam, Peter Bannas, Johannes Salamon, Lennart Well
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI. Neuro-oncology advances 6 (1) (2024)
Inka Ristow, Michael G Kaul, Maria Stark, Antonia Zapf, Christoph Riedel, Alexander Lenz, Victor F Mautner, Said C Farschtschi, Ivayla Apostolova, Gerhard Adam, Peter Bannas, Johannes Salamon, Lennart Well
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI. Neuro-oncology advances 6 (1) (2024)
Catena Kresbach, Matthias Dottermusch, Alicia Eckhardt, Inka Ristow, Petros Paplomatas, Lea Altendorf, Annika K Wefers, Michael Bockmayr, Sarra Belakhoua, Ivy Tran, Lara Pohl, Sina Neyazi, Helena Bode, Said C Farschtschi, Lennart Well, Reinhard E Friedrich, David Reuss, Matija Snuderl, Christian Hagel, Victor-Felix Mautner, Ulrich Schüller
Atypical Neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities. Neuro-oncology (2023)
Tim Godel, Philipp Bäumer, Said C Farschtschi, Barbara Hofstadler, Sabine Heiland, Mathias Gelderblom, Martin Bendszus, Victor-Felix Mautner
Spatial Distribution and Long-Term Alterations of Peripheral Nerve Lesions in Schwannomatosis. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Inka Ristow, Frederic Madesta, Lennart Well, Farzad Shenas, Felicia Wright, Isabel Molwitz, Said C Farschtschi, Peter Bannas, Gerhard Adam, Victor F Mautner, Rene Werner, Johannes Salamon
Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Neuro-oncology 24 (10) (2022)
Lennart Well, Kimberly Döbel, Lan Kluwe, Peter Bannas, Said C Farschtschi, Gerhard Adam, Victor-Felix Mautner, Johannes Salamon
Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth. PLoS genetics 17 (5) (2021)
Philipp Kollmann, Victor-Felix Mautner, Johannes Koeppen, Ralph Wenzel, Jan M Friedman, Johannes Salamon, Said C Farschtschi
MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools. Scientific reports 10 (1) (2020)
Said C Farschtschi, Tina Mainka, Markus Glatzel, Anna-Lena Hannekum, Michael Hauck, Mathias Gelderblom, Christian Hagel, Reinhard E Friedrich, Martin U Schuhmann, Alexander Schulz, Helen Morrison, Hildegard Kehrer-Sawatzki, Jan Luhmann, Christian Gerloff, Martin Bendszus, Philipp Bäumer, Victor-Felix Mautner
C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis. International journal of molecular sciences 21 (10) (2020)
Said C Farschtschi, Lan Kluwe, Su-Jin Park, Su-Jun Oh, Nancy Mah, Victor-Felix Mautner, Andreas Kurtz
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target. Cancer immunology, immunotherapy : CII 69 (7) (2020)
Said C Farschtschi, Lan Kluwe, Gerhard Schön, Reinhard E Friedrich, Jakob Matschke, Markus Glatzel, Joachim Weis, Christian Hagel, Victor-Felix Mautner
Distinctive low epidermal nerve fiber density in schwannomatosis patients provides a major parameter for diagnosis and differential diagnosis. Brain pathology (Zurich, Switzerland) 30 (2) (2019)